{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:04:56Z","timestamp":1777518296215,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":7497,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1034\/j.1600-6143.2002.20610.x","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T20:37:57Z","timestamp":1047328677000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Effects of Sirolimus on Lipids in Renal Allograft Recipients: An Analysis Using the Framingham Risk Model"],"prefix":"10.1016","volume":"2","author":[{"given":"Conrad B.","family":"Blum","sequence":"first","affiliation":[]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1034\/j.1600-6143.2002.20610.x_bib1","first-page":"S87","article-title":"Excerpts from United States Renal Data System. Annual Data Report. Causes of death","volume":"34","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib2","unstructured":"National Center for Health Statistics. Worktable GMWK290. Death rates for 72 selected causes by 10\u2010year age groups, race, and sex: United States, 1979\u201397. Hyattsville, MD 20782\u20132003: National Center for Health Statistics,Division of Data Services, 1999."},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF02564867","article-title":"Cardiovascular risk factors and diseases after renal transplantation","volume":"30","author":"Aker","year":"1998","journal-title":"Int Urol Nephrol"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0002-9343(88)90302-6","article-title":"Risk factors for accelerated atherosclerosis in renal transplant recipients","volume":"84","author":"Kasiske","year":"1988","journal-title":"Am J Med"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70145-3","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"Deierhoi","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00007890-199102000-00020","article-title":"Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine\u2010treated renal transplant recipients","volume":"51","author":"Hricik","year":"1991","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00007890-198706000-00018","article-title":"Hypertension after renal transplantation: a comparison of cyclosporine and conventional immunosuppression","volume":"43","author":"Chapman","year":"1987","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2796.1995.tb00901.x","article-title":"Hypertension in cyclosporin A\u2010treated patients is independent of circulating endothelin levels","volume":"238","author":"Forslund","year":"1995","journal-title":"J Intern Med"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1432-2277.1993.tb00631.x","article-title":"Post\u2010transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile","volume":"6","author":"Sutherland","year":"1993","journal-title":"Transpl Int"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1681\/ASN.V82294","article-title":"Late prednisone withdrawal in cyclosporine\u2010treated kidney transplant patients: a randomized study","volume":"8","author":"Hollander","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004872-199715030-00014","article-title":"Cyclosporine\u2010induced hypertension and decline in renal function in healthy volunteers","volume":"15","author":"Hansen","year":"1997","journal-title":"J Hypertens"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0025-6196(12)65772-3","article-title":"Cyclosporine\u2010induced hypertension after transplantation","volume":"60","author":"Textor","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicentre study","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","article-title":"Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial","volume":"68","author":"Pescovitz","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin) \u2010based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199805150-00023","article-title":"Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)","volume":"65","author":"Brattstrom","year":"1998","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib23","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib24","first-page":"48","article-title":"Letter","volume":"318","author":"Tobert","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007890-199401000-00014","article-title":"Long\u2010term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation","volume":"57","author":"Florijn","year":"1994","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2796.1996.474825000.x","article-title":"Hyperlipidaemia in renal transplant patients","volume":"239","author":"Aakhus","year":"1996","journal-title":"J Intern Med"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00007890-199211000-00019","article-title":"The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine\u2010treated kidney and kidney\u2010pancreas transplant recipients","volume":"54","author":"Hricik","year":"1992","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-9120(92)80021-8","article-title":"Effect of cyclosporin on plasma lipoproteins in bone marrow transplantation patients","volume":"25","author":"Lopez\u2010Miranda","year":"1992","journal-title":"Clin Biochem"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2362.1993.tb00968.x","article-title":"The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation","volume":"23","author":"Dimeny","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199305000-00015","article-title":"The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era","volume":"55","author":"Ingulli","year":"1993","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1989.03430010065032","article-title":"Effects of cyclosporine therapy on plasma lipoprotein levels","volume":"262","author":"Ballantyne","year":"1989","journal-title":"JAMA"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007890-199409000-00005","article-title":"Cyclosporine increases the oxidizability of low\u2010density lipoproteins in renal transplant recipients","volume":"58","author":"Apanay","year":"1994","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib33","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S0041-1345(98)00532-6","article-title":"Oxidizability of low\u2010density lipoproteins from Neoral and tacrolimus\u2010treated renal transplant patients","volume":"30","author":"Varghese","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","article-title":"Hyperhomocysteinemia in cyclosporine\u2010treated renal transplant recipients","volume":"61","author":"Arnadottir","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1046\/j.1523-1755.1998.00112.x","article-title":"Serum total homocysteine concentration before and after renal transplantation","volume":"54","author":"Arnadottir","year":"1998","journal-title":"Kidney Int"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.308.6925.363","article-title":"Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study","volume":"308","author":"Law","year":"1994","journal-title":"BMJ"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ije\/23.1.28","article-title":"Coronary risk in a British Punjabi population. comparative profile of non\u2010biochemical factors","volume":"23","author":"Williams","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-3156.1998.00199.x","article-title":"Arabian Peninsula men tend to insulin resistance and cardiovascular risk seen in South Asians","volume":"3","author":"Pugh","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"Suppl. 3","key":"10.1034\/j.1600-6143.2002.20610.x_bib39","first-page":"S93","article-title":"Risk factors leading to coronary heart disease among the black, Indian and white peoples of Durban","volume":"10","author":"Seedat","year":"1996","journal-title":"J Hum Hypertens"},{"issue":"Suppl. I","key":"10.1034\/j.1600-6143.2002.20610.x_bib40","first-page":"I","article-title":"Prediction of coronary heart disease in Japanese\u2010American men [abstract]","volume":"98","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1034\/j.1600-6143.2002.20610.x_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0091-7435(84)90047-1","article-title":"The seven countries study: 2,289 deaths in 15 years","volume":"13","author":"Keys","year":"1984","journal-title":"Prev Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.20610.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2002.20610.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352207085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352207085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-6143.2002.20610.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:26:15Z","timestamp":1761625575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352207085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S160061352207085X"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.20610.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Sirolimus on Lipids in Renal Allograft Recipients: An Analysis Using the Framingham Risk Model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1034\/j.1600-6143.2002.20610.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}